Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
New study shows how two species of gut bacteria boost the effectiveness of the chemotherapy drug cyclophosphamide by activating anticancer immune cells.
The hippocampus is a part of the brain that plays a huge role in memory and how knowledge is obtained. Learn more about its health and functions here.
Researchers have identified a new brain signaling pathway that alleviates depression when blocked; the discovery could open the door to new treatments.